Intrexon | XON - Capitalisation Boursière





Capitalisation Boursière Changement Date
Agenus USD 128M 21M 2026-03
Alaunos Therapeutics USD 6M 1000K 2026-06
Amgen USD 247.94B 20.06B 2026-11
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 213.88B 23.43B 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 24.6B 1.95B 2026-09
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.23B 108M 2026-09
MacroGenics USD 151M 143M 2026-11
MannKind USD 1.02B 237M 2026-11
Merck USD 375.59B 17.09B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Roche Holding CHF 270B 3.66B 2026-06
Thermo Fisher Scientific USD 249.58B 58.93B 2026-09
Veracyte USD 4.12B 414M 2026-11
Xencor USD 2.14B 281M 2026-11